Oligo Factory Launches Low-Scale Oligo Synthesis Capability to Broaden Support for Therapeutic and Diagnostic Researchers and Developers
Oligo Factory, a leading science-driven provider of high-quality custom DNA and RNA oligonucleotides for therapeutic, diagnostic, and life science applications, today announced the launch of its new low-scale oligo synthesis capability. This expansion enhances the company’s ability to broaden support for the development lifecycle of oligo-based therapeutics, including discovery, preclinical and toxicology studies, as well as molecular diagnostic applications. Oligo Factory will showcase its new and comprehensive FactorTx™ for Therapeutics product portfolio, which includes low- and mid-scale oligo synthesis scales, at TIDES USA, taking place May 19–22 in San Diego.
Oligo Factory Announces GMP Compliance
Oligo Factory, a leading manufacturer of high-quality oligonucleotides at scale, announces today that it is compliant with current Good Manufacturing Practices (GMP). This milestone emphasizes Oligo Factory's commitment to exceptional quality control, adherence to stringent global regulatory standards, and customer service.
Oligo Factory Opens New State-of-the-Art Oligo Manufacturing Facility
Oligo Factory, an independent manufacturer of custom oligonucleotides at scale, announced today it is opening a new oligo manufacturing facility in Holliston, MA, that will serve as the company’s new headquarters. With over 13,000 sq ft of combined bench space, offices, and labs for Oligo Factory’s next generation of synthesizers, the new facility increases Oligo Factory’s manufacturing capacity by 12x.
